EGRP Cancer Epidemiology News
June 2026
- The NCI Cohort Consortium Expands Opportunities for Cancer Researchers
- Funding Announcements
- NIH Highlighted Topics
- Grants Policy Notices
- Requests for Information
- Training Opportunities
- NCI & NIH News
The NCI Cohort Consortium Expands Opportunities for Cancer Researchers
The NCI Cohort Consortium promotes large-scale collaborations that pool prospective longitudinal data and biospecimens in order to conduct a wide range of cancer studies. It supports cancer epidemiology research in multiple ways, including:
- Promoting and fostering scientific collaborations among investigators working with epidemiological cohort studies focused on cancer etiology, survivorship, and other cancer-related outcomes.
- Providing a scientific forum where investigators can discuss shared challenges, exchange best practices, and address methodological issues in cohort research.
- Developing the next generation of investigators by offering networking and educational opportunities for trainees and early career researchers.
Within NCI, the Cohort Consortium is jointly coordinated by the Epidemiology and Genomics Research Program (EGRP) in the Division of Cancer Control and Population Sciences (DCCPS) and by the Division of Cancer Epidemiology and Genetics (DCEG).
Welcoming New Cohorts: Membership Opportunities Expanded
The Consortium has expanded its eligibility criteria to include a broader range of cohorts:
- Cancer incidence cohorts with baseline risk factor data that have enrollment (or target enrollment) of at least 10,000 participants.
- Cancer-related outcomes cohorts (e.g., survivorship) with baseline risk factor data that have at least 400 participants diagnosed with cancer.
Prospective member cohorts must demonstrate willingness to share data and actively participate in Consortium activities. The Consortium membership page provides details about applying for membership.
Even without formal membership, investigators and cohorts can still participate in Consortium activities, contribute data to project analyses, attend the Annual Meeting and scientific webinars, and join project groups. Learn more about participating in the NCI Cohort Consortium.
Supporting the Next Generation: The Associate Member Council
An important dimension of the Consortium is its formal commitment to early career investigators through the Associate Member Council (AMC). The AMC is the representative body of early career investigators within the Consortium, and its mission is to engage and support post-doctoral fellows and researchers — generally those within 10 years of their terminal degree — through professional development, career networking, and research collaborations. The AMC also aims to position the next generation of investigators for leadership roles within the Consortium. Membership is voluntary and open to anyone on the research team of a participating cohort or leading epidemiologic projects based primarily on Consortium data.
Valuable Collaboration Tools for Cohort Studies
EGRP supports the Cancer Epidemiology Descriptive Cohort Database (CEDCD), a publicly available, searchable database containing descriptive information for cohort studies that examine cancer incidence, mortality, and other health outcomes. Information collected on outcomes includes eligibility criteria, study size, types of data and biospecimens collected at baseline, numbers of participants diagnosed with cancer by site, and key contacts. Whether you are planning a new pooling project and need to identify cohorts with the variables and sample sizes you need, or you are a cohort looking to raise your profile and attract new collaborators, the CEDCD can be an invaluable resource.
DCCPS and NCI’s Center for Biomedical Informatics and Information Technology (CBIIT) led a cross-NCI collaboration to launch the Population Science Data Commons (PSDC)—a repository within the Cancer Research Data Commons (CRDC)—for population science data from NCI-supported studies. The PSDC aims to broaden access to these valuable research assets by making data available through both open and controlled access. Data can be submitted to the PSDC through the CRDC submission portal. Investigators can send questions to Dr. Erin Siegel and Heather Creasy or their NCI program officer.
Mark Your Calendar: 2026 Annual Meeting
The 2026 Annual Meeting of the NCI Cohort Consortium will be held on September 24–25, 2026, both in person and virtually. The meeting is open to all and brings together Consortium researchers to discuss emerging science, project progress, collaboration opportunities, and ideas for new scientific initiatives. Key deadlines include:
- Abstract submissions: July 10
- In-person registration: August 21
- Virtual registration: September 25
Getting Involved with the Cohort Consortium
To date, NCI Cohort Consortium members have launched more than 80 scientific collaborations, and more than 280 publications have resulted from Consortium projects. The Consortium's Project Hub provides a searchable list of these active and completed projects. The Hub is open to all interested researchers, and anyone can propose a potential project. Learn more about submitting a project application.
Whether you are looking to join an existing project, propose new research, apply for membership, connect with early career colleagues via the AMC, or simply explore what the Consortium has to offer, there are many ways to get involved. Visit the NCI Cohort Consortium website for a full overview of resources.
Funding Announcements
- RFA-CA-27-001, Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61, Clinical Trial Not Allowed)
- RFA-CA-27-002, Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33, Clinical Trial Not Allowed)
- PAR-27-073, Research Opportunities in Cancer Epidemiology Cohort Studies (U01, Clinical Trial Not Allowed)
- PAR-27-119, Center for Inherited Disease Research (CIDR) High Throughput Sequencing and Genotyping Resource Access (X01, Clinical Trial Not Allowed)
- PAR-27-062, Academic Career Excellence (ACE) Award (K32, Independent Clinical Trial Not Allowed)
- PA-27-100, NIH, CDC, and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44], Clinical Trial Optional)
- PA-27-102, NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42], Clinical Trial Optional)
- PA-27-101, NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44], Clinical Trial Optional)
- PA-27-098, SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1, Clinical Trial Optional)
- NOT-CA-26-012, Notice to Extend the Expiration Date for PAR-25-096 “Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21, Clinical Trial Not Allowed)”
- NOT-CA-26-011, Notice to Extend the Expiration Date for PAR-25-095 “Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01, Clinical Trial Not Allowed)”
NIH Highlighted Topics
- Advancing Autoimmune Disease Research: Integrating Genetic, Environmental, and Immunological Factors to Improve Diagnosis and Treatment
- Advancing Childhood and Adolescent & Young Adult (AYA) Cancer Research
- Behavioral and Cognitive Signals of Aging in Real-World Contexts
- Computational Modeling of Complex Processes Across Biological Scales
- Data Science and Artificial Intelligence Approaches for Biomedical, Biobehavioral and Social Science Research
- Digital Health and Artificial Intelligence Tools for Biomedical and Behavioral Research: Validity and Utility
- Enhancing Data Usage and Utility to Advance Biomedical Research
- Food Is Medicine
- New Approach Methodologies (NAMs) for Dietary Supplement and Nutrition Research
- Oral Health and Aging
- Research on the Role of Post-Translational Modifications in Human Health and Disease
- Training and Career Development in Dissemination and Implementation Science
Grants Policy Notices
- NOT-OD-26-069, Continuation of Modifications to Peer Review Practices
- NOT-OD-26-084, Reminder - Definition of Foreign Components
Requests for Information
- Federal Register Notice Proposed Rule, Regulation for Federal Financial Assistance – comments are requested by July 13, 2026
- NOT-OD-26-086, Proposal to Cap the Number of Simultaneous Research Project Grants per Principal Investigator to Support More Researchers and Maximize Scientific Productivity and Innovation – comments are requested by August 3, 2026
- NOT-OD-26-087, Request for Information on Measuring and Rewarding Scientific Impact – comments are requested by August 19, 2026
Training Opportunities
- NCI Cancer Prevention Fellowship Program (applications are due August 6, 2026)
NCI & NIH News
- Acknowledging Foreign Components throughout NIH Application and Award Processes
- FY25 Enrollment Data from NIH-Supported Clinical Research Now Available
- Clarifying Percent Effort and Support for Career Development (K) Award Recipients
- What Is the Difference Between an NIH Institute, Center, or Office’s Highlighted Topic and General Interest Area?
- NIH’s All of Us Research Program is Now the Largest Integrated Genomics and Health Database in the World
Stay Connected
Subscribe for Updates
Subscribe
You can subscribe and unsubscribe at any time by entering your email address and selecting your preferences on the page that follows.
Need Help?
EGRP staff can answer questions on grant funding, policies, and research resources. If you do not know who to contact we will do our best to connect you with someone who can help you.
Email Us(240) 276-6730